Telomeres and telomerase in sarcomas

Anticancer Research

Volumn 29, Issue 10, 2009, Pages 3833-3836

  Matsuo, Toshihiro ^a   Shimose, Shoji ^a   Kubo, Tadahiko ^a   Fujimori, Jun ^a   Yasunaga, Yuji ^a   Ochi, Mitsuo ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Alternative lengthening; hTERT; Prognosis; Review

Indexed keywords

TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ALTERNATIVE LENGTHENING OF TELOMERE; CANCER SURVIVAL; CELL STRUCTURE; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SARCOMA; SHORT SURVEY; SOFT TISSUE SARCOMA; TELOMERE;

HUMANS; SARCOMA; TELOMERASE; TELOMERE;

EID: 71949126268     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (38)

1. Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, Meyne J, Ratliff RL and Wu JR: A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 85: 6622-6626, 1988. (Pubitemid 18223496)
2. Blackburn EH: Structure and function of telomeres. Nature 350: 569-573, 1991.
3. Watson JD: Origin of concatemeric T7 DNA. Nat New Biol 239: 197-201, 1972.
4. Wright WE, Piatyszek MA, Rainey WE, Byrd W and Shay JW: Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18: 173-179, 1996. (Pubitemid 26116862)
5. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA and Shay JW: Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1: 249-255, 1995.
6. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y, Kodama T, Piatyszek MA, Shay JW and Matsuura Y: Telomerase activity in gastric cancer. Cancer Res 55: 3258-3262, 1995.
7. Hiyama E, Kodama T, Shinbara K, Iwao T, Itoh M, Hiyama K, Shay JW, Matsuura Y and Yokoyama T: Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res 57: 326-331, 1997. (Pubitemid 27036614)
8. Hiyama E and Hiyama K: Clinical utility of telomerase in cancer. Oncogene 21: 643-649, 2002.
9. Shay JW: Telomerase in cancer: diagnostic, prognostic, and therapeutic implications. Cancer J Sci Am 4: 26-34, 1998.
10. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA and Reddel RR: Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3: 1271-1274, 1997. (Pubitemid 27508830)
11. Bryan TM and Reddel RR: Telomere dynamics and telomerase activity in in vitro immortalised human cells. Eur J cancer 33: 767-773, 1997. (Pubitemid 27239487)
12. Henson JD, Hannay JA, McCarthy SW, Royds JA, Yeager TR, Robinson RA, Wharton SB, Jellinek DA, Arbuckle SM, Yoo J, Robinson BG, Learoyd DL, Stalley PD, Bonar SF, Yu D, Pollock RE and Reddel RR: A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas. Clin Cancer Res 11: 217-225, 2005. (Pubitemid 40075798)
13. Perrem K, Bryan TM, Englezou A, Hackl T, Moy EL and Reddel RR: Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids. Oncogene 18: 3383-3390, 1999. (Pubitemid 29286984)
14. Sanders RP, Drissi R, Billups CA, Daw NC, Valentine MB and Dome JS: Telomerase expression predicts unfavorable outcome in osteosarcoma. J Clin Oncol 22: 3790-3797, 2004. (Pubitemid 41095220)
15. Ulaner GA, Huang HY, Otero J, Zhao Z, Ben-Porat L, Satagopan JM, Gorlick R, Meyers P, Healey JH, Huvos AG, Hoffman AR and Ladanyi M: Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. Cancer Res 63: 1759-1763, 2003. (Pubitemid 36469314)
16. Schneider-Stock R, Epplen JT, Walter H, Radig K, Rys J, Epplen C, Hoang-Vu C, Niezabitowski A and Roessner A: Telomeric lengths and telomerase activity in liposarcomas. Mol Carcinog 24: 144-151, 1999. (Pubitemid 29115917)
17. Johnson JE, Varkonyi RJ, Schwalm J, Cragle R, Klein-Szanto A, Patchefsky A, Cukierman E, von Mehren M and Broccoli D: Multiple mechanisms of telomere maintenance exist in liposarcomas. Clin Cancer Res 11: 5347-5355, 2005. (Pubitemid 41060807)
18. Costa A, Daidone MG, Daprai L, Villa R, Cantù S, Pilotti S, Mariani L, Gronchi A, Henson JD, Reddel RR and Zaffaroni N: Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression. Cancer Res 66: 8918-8924, 2006. (Pubitemid 44449211)
19. Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Tahara E, Ide T and Ishikawa F: Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 18: 65-68, 1998. (Pubitemid 28027882)
20. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA and Weinberg RA: hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90: 785-795, 1997. (Pubitemid 27357969)
21. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB and Cech TR: Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955-959, 1997. (Pubitemid 27366681)
22. Yan P, Benhattar J, Coindre JM and Guillou L: Telomerase activity and hTERT mRNA expression can be heterogeneous and does not correlate with telomere length in soft tissue sarcomas. Int J Cancer 98: 851-856, 2002. (Pubitemid 34286680)
23. Aogi K, Woodman A, Urquidi V, Mangham DC, Tarin D and Goodison S: Telomerase activity in soft tissue and bone sarcomas. Clin Cancer Res 6: 4776-4781, 2000. (Pubitemid 32110419)
24. Terasaki T, Kyo S, Takakura M, Maida Y, Tsuchiya H, Tomita K and Inoue M: Analysis of telomerase activity and telomere length in bone and soft tissue tumors. Oncol Rep 11: 1307-1311, 2004.
25. Ulaner GA, Hoffman AR, Otero J, Huang HY, Zhao Z, Mazumdar M, Gorlick R, Meyers P, Healey JH amd Ladanyi M: Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomas. Genes Chromosomes Cancer 41: 155-162, 2004. (Pubitemid 39096741)
26. Umehara N, Ozaki T, Sugihara S, Kunisada T, Morimoto Y, Kawai A, Nishida K, Yoshida A, Murakami T and Inoue H: Influence of telomerase activity on bone and soft tissue tumors. J Cancer Res Clin Oncol 130: 411-416, 2004. (Pubitemid 39044344)
27. Matsuo T, Sugita T, Shimose S, Kubo T, Yasunaga Y, Hiyama E and Ochi M: Postradiation malignant fibrous histiocytoma and osteosarcoma of a patient with high telomerase activities. Anticancer Res 25: 2951-2955, 2005. (Pubitemid 41044684)
28. Tomoda R, Seto M, Tsumuki H, Iida K, Yamazaki T, Sonoda J, Matsumine A and Uchida A: Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors. Cancer 95: 1127-1133, 2002. (Pubitemid 34925366)
29. Sotillo-PiSeiro E, Sierrasesúmaga L and Patiño-García A: Telomerase activity and telomere length in primary and metastatic tumors from pediatric bone cancer patients. Pediatr Res 55: 231-235, 2004.
30. Ohali A, Avigad S, Cohen IJ, Meller I, Rollender Y, Issakov J, Gelernter I, Goshen Y, Yaniv I and Zaizov R: Association between telomerase activity and outcome in patients with nonmetastatic Ewing family of tumors. J Clin Oncol 21: 3836-3843, 2003. (Pubitemid 46606239)
31. Martin JA, Forest E, Block JA, Klingelhutz AJ, Whited B, Gitelis S, Wilkey A and Buckwalter JA: Malignant transformation in human chondrosarcoma cells supported by telomerase activation and tumor suppressor inactivation. Cell Growth Differ 13: 397-407, 2002.
32. Matsuo T, Shay JW, Wright WE, Hiyama E, Shimose S, Kubo T, Sugita T, Yasunaga Y and Ochi M: Telomere-maintenance mechanisms in soft tissue malignant fibrous histiocytomas. J Bone Joint Surg Am 91: 928-937, 2009.
33. Schneider-Stock R, Jaeger V, Rys J, Epplen JT and Roessner A: High telomerase activity and high HTPT mRNA expression differentiate pure myxoid and myxoid/round-cell liposarcomas. Int J Cancer 89: 63-68, 2000. (Pubitemid 30078751)
34. Wright WE, Piatyszek MA, Rainey WE, Byrd W and Shay JW: Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18: 173-179, 1996. (Pubitemid 26116862)
35. Forsyth NR, Wright WE and Shay JW: Telomerase and differentiation in multicellular organisms: turn it off, turn it on, and turn it off again. Differentiation 69: 188-197, 2002.
36. Asai A, Oshima Y, Yamamoto Y, Uochi TA, Kusaka H, Akinaga S, Yamashita Y, Pongracz K, Pruzan R, Wunder E, Piatyszek M, Li S, Chin AC, Harley CB and Gryaznov S: A novel telomerase template antagonist (GRN163) as a potential anticancer agent. Cancer Res 63: 3931-3939, 2003. (Pubitemid 36917908)
37. Harley CB: Telomerase and cancer therapeutics. Nat Rev Cancer 8: 167-179, 2008.
38. Jackson SR, Zhu CH, Paulson V, Watkins L, Dikmen ZG, Gryaznov SM, Wright WE and Shay JW: Antiadhesive effects of GRN163L-an oligonucleotide N3′->P5′ thio-phosphoramidate targeting telomerase. Cancer Res 67: 1121-1129, 2007. (Pubitemid 46270769)